JP2023540212A5 - - Google Patents
Info
- Publication number
- JP2023540212A5 JP2023540212A5 JP2023513088A JP2023513088A JP2023540212A5 JP 2023540212 A5 JP2023540212 A5 JP 2023540212A5 JP 2023513088 A JP2023513088 A JP 2023513088A JP 2023513088 A JP2023513088 A JP 2023513088A JP 2023540212 A5 JP2023540212 A5 JP 2023540212A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- mesoderm
- composition
- cell
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063069904P | 2020-08-25 | 2020-08-25 | |
| US63/069,904 | 2020-08-25 | ||
| PCT/CA2021/051181 WO2022040798A1 (en) | 2020-08-25 | 2021-08-25 | Compositions and methods for generating human yolk sac-like hematopoietic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540212A JP2023540212A (ja) | 2023-09-22 |
| JP2023540212A5 true JP2023540212A5 (cg-RX-API-DMAC7.html) | 2024-08-30 |
Family
ID=80354070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513088A Pending JP2023540212A (ja) | 2020-08-25 | 2021-08-25 | ヒト卵黄嚢様造血細胞を生成するための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230374458A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4204544A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023540212A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3190402A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022040798A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202022003132U1 (de) | 2021-04-01 | 2025-02-17 | The Regents Of The University Of California | Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten |
| US20260108560A1 (en) * | 2022-07-13 | 2026-04-23 | The Regents Of The University Of California | Transplanting stem cell-derived microglia to treat leukodystrophies |
| KR20240076715A (ko) * | 2022-11-17 | 2024-05-30 | 주식회사 씨티셀즈 | 미분화 줄기세포로부터 자연 살해 세포로의 분화 방법 및 이의 용도 |
| CN120641558A (zh) * | 2022-12-28 | 2025-09-12 | 国立大学法人千叶大学 | 细胞分化度的调节方法 |
| WO2024216379A1 (en) * | 2023-04-18 | 2024-10-24 | University Health Network | Use of macrophages for improved pancreatic cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970912B1 (en) * | 2013-03-13 | 2019-03-06 | Wisconsin Alumni Research Foundation | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
| EP3497204B1 (en) * | 2016-08-10 | 2025-04-30 | Indiana University Research & Technology Corporation | Method for generating mesoderm and/or endothelial colony forming cell-like cells having in vivo blood vessel forming capacity |
-
2021
- 2021-08-25 EP EP21859460.4A patent/EP4204544A4/en active Pending
- 2021-08-25 CA CA3190402A patent/CA3190402A1/en active Pending
- 2021-08-25 JP JP2023513088A patent/JP2023540212A/ja active Pending
- 2021-08-25 WO PCT/CA2021/051181 patent/WO2022040798A1/en not_active Ceased
- 2021-08-25 US US18/023,289 patent/US20230374458A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220228118A1 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | |
| Tian et al. | Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells | |
| CN107429230B (zh) | 用于诱导造血细胞分化的方法和组合物 | |
| CA2856322C (en) | Populations of hematopoietic progenitors and methods of enriching stem cells therefor | |
| JP2023058748A5 (cg-RX-API-DMAC7.html) | ||
| AU2011227274B2 (en) | Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions | |
| WO2023240763A1 (zh) | 一种诱导iPSC分化获得CD34+细胞和NK细胞的方法及其应用 | |
| JP5928681B2 (ja) | ヒト多能性幹細胞からの造血幹細胞の効率的な誘導方法 | |
| US8278101B2 (en) | Stem cell bioprocessing and cell expansion | |
| WO2023138680A9 (zh) | 诱导细胞分化的方法 | |
| US20080108044A1 (en) | In vitro differentiation of hematopoietic cells from primate embryonic stem cells | |
| CN114874973A (zh) | 获得成熟肝细胞的培养基及培养方法 | |
| Philonenko et al. | Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines | |
| CN101684454B (zh) | 一种定型内胚层细胞的制备和分离方法 | |
| US20250223558A1 (en) | Large scale manufacturing of ipsc derived hsc and progeny | |
| Mejía-Cruz et al. | Generation of organotypic multicellular spheres by magnetic levitation: model for the study of human hematopoietic stem cells microenvironment | |
| Orlovskaya et al. | Hematopoietic differentiation of embryonic stem cells | |
| JP2024523332A5 (cg-RX-API-DMAC7.html) | ||
| US20210371824A1 (en) | Production of megakaryocytes in bioreactors | |
| WO2024253186A1 (ja) | 培地組成物および培養方法 | |
| CN120303394A (zh) | 用于分化多能干细胞的方法和组合物及衍生的自然杀伤细胞 | |
| CN101735975A (zh) | 一种利用单层培养技术制备和分离定型内胚层细胞的方法 | |
| HK40122734A (en) | Methods and compositions for differentiation of pluripotent stem cells and derived natural killer cells | |
| CN121320248A (zh) | 一种通过iPSC分化诱导获得并激活扩增自然杀伤细胞的方法 | |
| HK40061773A (en) | Methods and compositions for inducing hematopoietic cell differentiation |